Skip to main content

Advertisement

SpringerLink
Log in

Sex Disparities in Outcomes of Patients with Coronary Disease

  • Secondary Intervention (JM Foody, Section Editor)
  • Published:
Current Cardiovascular Risk Reports Aims and scope Submit manuscript

Abstract

Cardiovascular disease is the number one cause of death for women. It is vital to note that since 1984, the annual number of cardiovascular deaths for women has exceeded that for men. In this review, we explore the most recent data on sex-differences in outcomes of patients with coronary artery disease including changes in awareness, diagnosis of coronary disease, gender disparities in treatment of acute coronary syndromes, and barriers to closing the gender gap in preventive care. In addition, the most recent guidelines for prevention of cardiovascular disease in women are discussed and issues related to the challenges related to enrollment of women in clinical trials are explored.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: •• Of major importance

  1. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics–2011 update: a report from the American Heart Association. Circulation. 2011;123:e18–209.

    Article  PubMed  Google Scholar 

  2. Mosca L, Mochari-Greenberger H, Dolor RJ, Newby LK, Robb KJ. Twelve-year follow-up of American women's awareness of cardiovascular disease risk and barriers to heart health. Circ Cardiovasc Qual Outcomes. 2010;3:120–7.

    Article  PubMed  Google Scholar 

  3. Adler NE, Aguilar-Gaxiola S, Awaro H, Anthony M, Brown DR, Col N, et al. Women's health research: progress, pitfalls, and promise. Washington DC: National Acadmies Press; 2010.

    Google Scholar 

  4. Mosca L, Benjamin EJ, Berra K, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women–2011 update: a guideline from the American heart association. Circulation. 2011;123:1243–62.

    Article  PubMed  Google Scholar 

  5. Gibbons RJ, Balady GJ, Bricker JT, et al. ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American college of cardiology/American heart association task force on practice guidelines (committee to update the 1997 exercise testing guidelines). Circulation. 2002;106:1883–92.

    Article  PubMed  Google Scholar 

  6. Mieres JH, Shaw LJ, Arai A, et al. Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease: consensus statement from the cardiac imaging committee, council on clinical cardiology, and the cardiovascular imaging and intervention committee, council on cardiovascular radiology and intervention, American heart association. Circulation. 2005;111:682–96.

    Article  PubMed  Google Scholar 

  7. Shaw LJ, Mieres JH, Hendel RH, et al. Comparative effectiveness of exercise electrocardiography with or without myocardial perfusion single photon emission computed tomography in women with suspected coronary artery disease: results from the what is the optimal method for ischemia evaluation in women (WOMEN) trial. Circulation. 2011;124:1239–49.

    Article  PubMed  Google Scholar 

  8. Cerci MS, Cerci JJ, Cerci RJ, et al. Myocardial perfusion imaging is a strong predictor of death in women. JACC Cardiovasc Imaging. 2011;4:880–8.

    Google Scholar 

  9. Shaw LJ, Min JK, Narula J, et al. Sex differences in mortality associated with computed tomographic angiographic measurements of obstructive and nonobstructive coronary artery disease: an exploratory analysis. Circ Cardiovasc Imaging. 2010;3:473–81.

    Article  PubMed  Google Scholar 

  10. Hochman JS, Tamis JE, Thompson TD, et al. Sex, clinical presentation, and outcome in patients with acute coronary syndromes. global use of strategies to open occluded coronary arteries in acute coronary syndromes IIB investigators. N Engl J Med. 1999;341:226–32.

    Article  PubMed  CAS  Google Scholar 

  11. Berger JS, Elliott L, Gallup D, et al. Sex differences in mortality following acute coronary syndromes. JAMA. 2009;302:874–82.

    Article  PubMed  CAS  Google Scholar 

  12. Jneid H, Fonarow GC, Cannon CP, et al. Sex differences in medical care and early death after acute myocardial infarction. Circulation. 2008;118:2803–10.

    Article  PubMed  Google Scholar 

  13. Vaccarino V, Parsons L, Peterson ED, Rogers WJ, Kiefe CI, Canto J. Sex differences in mortality after acute myocardial infarction: changes from 1994 to 2006. Arch Intern Med. 2009;169:1767–74.

    Article  PubMed  Google Scholar 

  14. •• Canto JG, Rogers WJ, Goldberg RJ, et al. Association of age and sex with myocardial infarction symptom presentation and in-hospital mortality. JAMA. 2012;307:813–22. In this registry of hospitalized patients with MI, women were more likely than men to present without chest pain and had a higher mortality than men within the same age group. Gender differences in clinical presentations were most marked in the youngest age group.

    Article  PubMed  CAS  Google Scholar 

  15. Vaccarino V, Parsons L, Every NR, Barron HV, Krumholz HM. Sex-based differences in early mortality after myocardial infarction. national registry of myocardial infarction 2 participants. N Engl J Med. 1999;341:217–25.

    Article  PubMed  CAS  Google Scholar 

  16. Champney KP, Frederick PD, Bueno H, et al. The joint contribution of sex, age and type of myocardial infarction on hospital mortality following acute myocardial infarction. Heart. 2009;95:895–9.

    Article  PubMed  CAS  Google Scholar 

  17. Andrikopoulos GK, Tzeis SE, Pipilis AG, et al. Younger age potentiates post myocardial infarction survival disadvantage of women. Int J Cardiol. 2006;108:320–5.

    Article  PubMed  Google Scholar 

  18. Akhter N, Milford-Beland S, Roe MT, Piana RN, Kao J, Shroff A. Gender differences among patients with acute coronary syndromes undergoing percutaneous coronary intervention in the American college of cardiology-national cardiovascular data registry (ACC-NCDR). Am Heart J. 2009;157:141–8.

    Article  PubMed  Google Scholar 

  19. Blomkalns AL, Chen AY, Hochman JS, et al. Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (can rapid risk stratification of unstable angina patients suppress adverse outcomes with early implementation of the American College of Cardiology/American Heart Association guidelines) national quality improvement initiative. J Am Coll Cardiol. 2005;45:832–7.

    Article  PubMed  Google Scholar 

  20. Alexander KP, Chen AY, Newby LK, et al. Sex differences in major bleeding with glycoprotein IIb/IIIa inhibitors: results from the CRUSADE (can rapid risk stratification of unstable angina patients suppress adverse outcomes with early implementation of the ACC/AHA guidelines) initiative. Circulation. 2006;114:1380–7.

    Article  PubMed  CAS  Google Scholar 

  21. Wang TY, Angiolillo DJ, Cushman M, et al. Platelet biology and response to antiplatelet therapy in women: implications for the development and use of antiplatelet pharmacotherapies for cardiovascular disease. J Am Coll Cardiol. 2012;59:891–900.

    Article  PubMed  CAS  Google Scholar 

  22. Lansky AJ. Outcomes of percutaneous and surgical revascularization in women. Prog Cardiovasc Dis. 2004;46:305–19.

    Article  PubMed  Google Scholar 

  23. Mehta RH, Stebbins AS, Lopes RD, et al. Comparison of incidence of bleeding and mortality of men versus women with ST-elevation myocardial infarction treated with fibrinolysis. Am J Cardiol. 2012;109:320–6.

    Google Scholar 

  24. Mehran R, Lansky AJ, Witzenbichler B, et al. Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomized controlled trial. Lancet. 2009;374:1149–59.

    Article  PubMed  Google Scholar 

  25. Leifheit-Limson EC, Reid KJ, Kasl SV, et al. The role of social support in health status and depressive symptoms after acute myocardial infarction: evidence for a stronger relationship among women. Circ Cardiovasc Qual Outcomes. 2010;3:143–50.

    Article  PubMed  Google Scholar 

  26. Orth-Gomer K, Schneiderman N, Wang HX, Walldin C, Blom M, Jernberg T. Stress reduction prolongs life in women with coronary disease: the Stockholm women's intervention trial for coronary heart disease (SWITCHD). Circ Cardiovasc Qual Outcomes. 2009;2:25–32.

    Article  PubMed  Google Scholar 

  27. Lewis WR, Ellrodt AG, Peterson E, et al. Trends in the use of evidence-based treatments for coronary artery disease among women and the elderly: findings from the get with the guidelines quality-improvement program. Circ Cardiovasc Qual Outcomes. 2009;2:633–41.

    Article  PubMed  Google Scholar 

  28. Mosca L, Banka CL, Benjamin EJ, et al. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation. 2007;115:1481–501.

    Article  PubMed  Google Scholar 

  29. Fraser A, Nelson SM, Macdonald-Wallis C, et al. Associations of pregnancy complications with calculated cardiovascular disease risk and cardiovascular risk factors in middle age: the Avon longitudinal study of parents and children. Circulation. 2012;125:1367–80.

    Article  PubMed  CAS  Google Scholar 

  30. Hsia J, Rodabough RJ, Manson JE, et al. Evaluation of the American heart association cardiovascular disease prevention guideline for women. Circ Cardiovasc Qual Outcomes. 2010;3:128–34.

    Article  PubMed  Google Scholar 

  31. Berger JS, Roncaglioni MC, Avanzini F, Pangrazzi I, Tognoni G, Brown DL. Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials. JAMA. 2006;295:306–13.

    Article  PubMed  CAS  Google Scholar 

  32. Dorresteijn JA, Visseren FL, Ridker PM, et al. Aspirin for primary prevention of vascular events in women: individualized prediction of treatment effects. Eur Heart J. 2011;32:2962–9.

    Article  PubMed  CAS  Google Scholar 

  33. Mizuno K, Nakaya N, Ohashi Y, et al. Usefulness of pravastatin in primary prevention of cardiovascular events in women: analysis of the management of elevated cholesterol in the primary prevention group of adult Japanese (MEGA study). Circulation. 2008;117:494–502.

    Article  PubMed  CAS  Google Scholar 

  34. •• Kostis WJ, Cheng JQ, Dobrzynski JM, Cabrera J, Kostis JB. Meta-analysis of statin effects in women versus men. J Am Coll Cardiol. 2012;59:572–82. In a large meta-analysis of 18 randomized clinical trials of statins with sex-specific outcomes, statin therapy was associated with significant decreases in cardiovascular events and in all-cause mortality in women and men.

    Article  PubMed  CAS  Google Scholar 

  35. Sattar N, Preiss D, Murray HM, et al. Statins and risk of incident diabetes: a collaborative meta-analysis of randomized statin trials. Lancet. 2010;375:735–42.

    Article  PubMed  CAS  Google Scholar 

  36. Mosca L, Merz NB, Blumenthal RS, et al. Opportunity for intervention to achieve American heart association guidelines for optimal lipid levels in high-risk women in a managed care setting. Circulation. 2005;111:488–93.

    Article  PubMed  Google Scholar 

  37. Barnhart J, Lewis V, Houghton JL, Charney P. Physician knowledge levels and barriers to coronary risk prevention in women: survey results from the women and heart disease physician education initiative. WHI. 2007;17:93–100.

    PubMed  Google Scholar 

  38. Mosca L, Appel LJ, Benjamin EJ, et al. Evidence-based guidelines for cardiovascular disease prevention in women. Circulation. 2004;109:672–93.

    Article  PubMed  Google Scholar 

  39. Maas AH, van der Schouw YT, Regitz-Zagrosek V, et al. Red alert for women's heart: the urgent need for more research and knowledge on cardiovascular disease in women: proceedings of the workshop held in Brussels on gender differences in cardiovascular disease, 29. Eur Heart J. 2010;32:1362–8.

    Article  Google Scholar 

  40. •• Melloni C, Berger JS, Wang TY, et al. Representation of women in randomized clinical trials of cardiovascular disease prevention. Circ Cardiovasc Qual Outcomes. 2010;3:135–42. Enrollment of women in randomized clinical trials has increased over time but remains low relative to their overall representation in disease populations.

    Article  PubMed  Google Scholar 

  41. Dhruva SS, Bero LA, Redberg RF. Gender bias in studies for food and drug administration premarket approval of cardiovascular devices. Circ Cardiovasc Qual Outcomes. 2011;4:165–71.

    Article  PubMed  Google Scholar 

  42. Dhruva SS, Redberg RF. Clinical trial enrollment and progress in women's health. JAMA. 2011;305:1197; author reply 1197–8.

    Google Scholar 

  43. Mosca L. Controversy and consensus about statin use: it is not about the sex. J Am Coll Cardiol. 2012;59:583–4.

    Article  PubMed  Google Scholar 

Download references

Disclosure

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

  1. Department of Medicine Division of Cardiovascular Disease, HSC T-16 080, Stony Brook University Medical Center, Stony Brook, NY, 11974-8167, USA

    Travis Bench, Ronald Flores & Kathleen Stergiopoulos

Authors
  1. Travis Bench
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ronald Flores
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kathleen Stergiopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kathleen Stergiopoulos.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bench, T., Flores, R. & Stergiopoulos, K. Sex Disparities in Outcomes of Patients with Coronary Disease. Curr Cardiovasc Risk Rep 6, 479–486 (2012). https://doi.org/10.1007/s12170-012-0253-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12170-012-0253-1

Keywords

Search

Navigation